Title
Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic
UMMS Affiliation
Division of Hematology and Oncology, Department of Medicine
Publication Date
2020-07-03
Document Type
Article
Disciplines
Health Services Administration | Hematology | Hemic and Lymphatic Diseases | Immune System Diseases | Infectious Disease | Medical Microbiology | Virus Diseases
Abstract
It is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.
Keywords
COVID-19, Coronavirus, Epidemiology, Immune responses, Pandemics, Plasma cell, SARS coronavirus, Virus classification
DOI of Published Version
10.1002/jmv.26251
Source
Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251. Epub ahead of print. PMID: 32619062. Link to article on publisher's site
Journal/Book/Conference Title
Journal of medical virology
Related Resources
PubMed ID
32619062
Repository Citation
Sahu KK, Siddiqui AD, Rezaei N, Cerny J. (2020). Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. COVID-19 Publications by UMMS Authors. https://doi.org/10.1002/jmv.26251. Retrieved from https://escholarship.umassmed.edu/covid19/66